Please login to the form below

Not currently logged in
Email:
Password:

Bayer appoints new head of global innovation and development, consumer health

Dr Sharon James succeeds Dr John O’Mullane

Life sciences company Bayer has appointed Dr Sharon James as head of global innovation and development for consumer health, following the retirement of her predecessor Dr John O’Mullane.

Dr James joins from Reckitt Benckiser, where she mostly recently held the position of senior vice president, head of global research and development at the company’s global headquarters in Slough, UK.

She has also previously held various senior roles for PepsiCo and GlaxoSmithKline.

Erica Mann, member of the board of management and president of Bayer AG’s consumer health division, said: “With more than 25 years’ experience in the fast-moving consumer goods and consumer product sector, Sharon has a proven record of developing and supporting products for leading consumer brands.”

“I am excited that Sharon is joining consumer health, and know that under her leadership Bayer will continue to successfully develop and deliver new innovative self-care solutions that help people around the world be a little healthier every day.”

Dr James’ product development experience spans health, personal and home care categories where she has delivered transformative and consumer-loved innovation internationally.

4th October 2017

From: Sales

Share

Tags

COVID-19 Updates and Daily News

Featured jobs

PMHub

Add my company
Nucleus Global

Nucleus Global is the largest specialist medical communications network in the world. Globally, we have over 700 experts delivering world-class...

Latest intelligence

The search for treatments for Parkinson’s disease
The research requires resilience but pharma is urged to ‘keep innovating, keep trying’...
Margot Hannah, OPEN Health - A personal perspective of LGBT+ and diversity.
Ditch the Label – it’s just me....
The impact of COVID-19 on clinical trials
As all industry sectors work to assess both the impact and the optimal path forward, the effects are expected to be diverse and long-lasting...

Infographics